Novo Nordisk and Celgene lead January pharma M&A
Novo’s bid
X
Novo Nordisk and Celgene lead January pharma M&A
https://pharmaphorum.com/news/novo-nordisk-celgene-lead-january-pharma-ma/
Mergers and acquisitions
Takeda to buy Ariad for $5.2bn
Pharma M&A could surge in 2017, says report
Johnson & Johnson back in ‘exclusive’ talks to buy Actelion
Deal expected to be worth around $30 billion.
BIND accepts Pfizer bid following bankruptcy
Bid of $20 million may be enough to acquire all of BIND’s assets.
UCB: growing sales and growing bones
The specialist pharma company is set to expand into osteoporosis through its partnership with Amgen
1 2